<SEC-DOCUMENT>0000785161-17-000078.txt : 20171211
<SEC-HEADER>0000785161-17-000078.hdr.sgml : 20171211
<ACCEPTANCE-DATETIME>20171211165214
ACCESSION NUMBER:		0000785161-17-000078
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171207
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171211
DATE AS OF CHANGE:		20171211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHSOUTH CORP
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		171250030

	BUSINESS ADDRESS:	
		STREET 1:		3660 GRANDVIEW PARKWAY
		STREET 2:		SUITE 200
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35243
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		3660 GRANDVIEW PARKWAY
		STREET 2:		SUITE 200
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35243

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>item502form8-kdecember2017.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sb0a2e19212674745a28c209ca64b3e94"></a></div><div style="line-height:120%;padding-top:12px;text-align:center;"><hr></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:13pt;"><font style="font-family:inherit;font-size:13pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-top:13px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (date of earliest event reported): December 7, 2017 </font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">HealthSouth Corporation</font></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of Registrant as specified in its Charter)</font></div><div style="line-height:120%;padding-top:24px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Delaware</font></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(State or Other Jurisdiction of Incorporation)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.40625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">001-10315</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">63-0860407</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(IRS Employer Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">3660 Grandview Parkway, Suite 200, Birmingham, Alabama 35243</font></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices, Including Zip Code)</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">(205)&#160;967-7116</font></div><div style="line-height:120%;padding-top:2px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:12px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. &#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;      </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange   Act. </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s17ad31915f4445c996adf97dff7938af"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 5.02. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Election of Director.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 7, 2017, the Board of Directors (the &#8220;Board&#8221;) of HealthSouth Corporation (the &#8220;Corporation&#8221;), unanimously approved an increase in the number of directors of the Corporation to eleven, and, upon the recommendation of its Nominating/Corporate Governance Committee, unanimously approved the appointment of Ms. Nancy M. Schlichting as a director to fill the vacant seat, effective December 11, 2017. She will initially serve on the Compliance and Quality of Care Committee. The Board found Ms. Schlichting to be independent for purposes of the listing standards of The New York Stock Exchange and the Corporation&#8217;s Corporate Governance Guidelines. She will be compensated for her board service in accordance with the standard compensation practices for non-employee directors, which are more fully described in the &#8220;Corporate Governance and Board Structure - Compensation of Directors&#8221; section of the Corporation&#8217;s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 24, 2017. There are no arrangements or understandings between Ms. Schlichting and any other person pursuant to which she was selected to serve as a director of the Corporation, nor is she a participant in any related party transactions required to be reported pursuant to Item 404(a) of Regulation S-K. On December&#160;11, 2017, the Corporation issued a press release, attached hereto as Exhibit 99.1, announcing Ms. Schlichting&#8217;s appointment to the Corporation&#8217;s Board.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4230cf8b3f70436bb5c4040fa3550aab"></a></div><div style="line-height:120%;padding-bottom:13px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 9.01. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Statements and Exhibits.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) Exhibits </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:18px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="hlsboardannouncementrelease.htm"><font style="font-family:inherit;font-size:10pt;">99.1</font></a></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="hlsboardannouncementrelease.htm"><font style="font-family:inherit;font-size:10pt;">Press Release of HealthSouth Corporation, dated December 11, 2017.</font></a></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="scef398ca17554f54abb78dbbedd3705e"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:55.859375%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="3"></td></tr><tr><td style="width:8%;"></td><td style="width:12%;"></td><td style="width:80%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HEALTHSOUTH CORPORATION</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:7pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160; Patrick Darby</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patrick Darby</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President, General Counsel</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated: December 11, 2017</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hlsboardannouncementrelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3be7807f3f8143e8af4edc463e825d55"></a></div><div><div style="line-height:120%;padding-bottom:13px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:13px;text-align:center;"><img src="hlslogo2017a01.jpg" alt="hlslogo2017a01.jpg" style="height:81px;width:682px;"></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:680px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:500px;"></td><td style="width:180px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Media Contact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">December 11, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Casey Lassiter, 205 447-6410</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For Immediate Release</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">casey.lassiter@healthsouth.com</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Investor Relations Contact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Crissy Carlisle, 205 970-5860</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">crissy.carlisle@healthsouth.com</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">HealthSouth Appoints Nancy M. Schlichting to Board of Directors</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">BIRMINGHAM, Ala., Dec. 11, 2017 -- HealthSouth Corporation (NYSE: HLS), one of the nation's largest providers of post-acute healthcare services, offering both facility-based and home-based patient care, today announced the appointment of Nancy M. Schlichting as an independent director, effective today. With this appointment, the Board will expand to 11 directors. </font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ms. Schlichting joins the HealthSouth Board with extensive healthcare experience and expertise in healthcare delivery. Her career in healthcare administration spans 35 years in senior level executive positions, most recently serving as the President and Chief Executive Officer at Henry Ford Health System, Inc. from June 2003 until December 2016. Prior to that, Ms. Schlichting served as Executive Vice President and Chief Operating Officer from 1998-2003. She also served as President and CEO of HFHS&#8217;s Henry Ford Hospital from 2001-2003. During her time at HFHS, the company garnered significant national recognition, including the Malcolm Baldrige National Quality Award and the John M. Eisenberg Patient Safety and Quality Award. Prior to joining HFHS in 1998, Ms. Schlichting served as the President of the Eastern Region of Catholic Health Initiatives, President and Chief Executive Officer of Riverside Methodist Hospitals and Executive Vice President and Chief Operating Officer of Akron City Hospital and Summa Health System. Ms. Schlichting currently serves on the boards of Walgreens Boots Alliance, Inc. and Hill-Rom Holdings, Inc.</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;Nancy is one of the most experienced and successful executives in the healthcare industry, and we&#8217;re pleased that she will be joining HealthSouth&#8217;s Board,&#8221; said Leo I. Higdon Jr., Chairman of HealthSouth&#8217;s Board of Directors. &#8220;With her operational insight and financial acumen, Nancy helped guide the Henry Ford Health System through a dramatic financial turnaround, and created positive revenue growth for 12 consecutive years. Her appointment reflects our Board&#8217;s commitment to adding new skills and perspectives through ongoing long-term succession planning as we continue to advance our position as the leading provider of integrated post-acute care solutions in a rapidly changing healthcare environment.&#8221;</font></div><div style="line-height:120%;padding-bottom:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;I am excited to join the HealthSouth Board and help advance the Company&#8217;s mission to create superior patient outcomes and best-in-class solutions for healthcare systems and payors,&#8221; said Ms. Schlichting. &#8220;The Company is well-positioned to coordinate patients&#8217; care across the healthcare continuum, and I look forward to working with the Board and management team to deliver further value for all HealthSouth stockholders.&#8221;</font></div><div><a name="s7b3d158bee554ecb8cc4e41f075c5614"></a></div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HealthSouth is one of the nation's largest providers of post-acute healthcare services, offering both facility-based and home-based patient care in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. HealthSouth can be found on the Web at </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">www.healthsouth.com</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>hlslogo2017a01.jpg
<TEXT>
begin 644 hlslogo2017a01.jpg
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M"6G_ ']:@?'75F(5=#M"2< >:W)KV:V>26UADF0)(R*74= 2.14M(S!5+,0
M!DD]J\AU;XX3V^JW,&FZ7;W%I&Y6.:21@9 .^!VJG_PO;5?^@):?]_6H_P"%
M[:K_ - 2T_[^M6AX?^,M]JWB"QTZYTJVABNIA$TBR,2N>GZXKUNBBLSQ)K T
M#P[?:J4$AM8BX0G 8]A^=>3_ /"]M5_Z EI_W]:C_A>VJ_\ 0$M/^_K4?\+V
MU7_H"6G_ ']:M_P3\4=3\6>)8M+DTJV@B,;R22)(Q*@#_$@5Z916+XNU_P#X
M1CPS=ZLL:RO !LC8X#L2 !^M>7?\+VU7_H"6G_?UJ/\ A>VJ_P#0$M/^_K4?
M\+VU7_H"6G_?UJ/^%[:K_P! 2T_[^M1_PO;5?^@):?\ ?UJ/^%[:K_T!+3_O
MZU'_  O;5?\ H"6G_?UJ/^%[:K_T!+3_ +^M1_PO;5?^@):?]_6H_P"%[:K_
M - 2T_[^M1_PO;5?^@):?]_6H_X7MJO_ $!+3_OZU'_"]M5_Z EI_P!_6H_X
M7MJG_0$M/^_K5ZUX?U"XU;0+'4;J%8)KJ%96C4DA<C('/M6C167XEU@:!X<O
MM5V!S:Q%U1C@,W0#\R*\H_X7MJO_ $!+3_OZU'_"]M5_Z EI_P!_6H_X7MJO
M_0$M/^_K5T'@CXH:GXL\21Z7)I5O!$8WD>1)&)4 ?XD5Z74-W>6UA;M<7=Q'
M;PI]Z21@H'XFN#UCXS^&]/9H[%)]2<=XAL3_ +Z/]!7*W?QTU9V/V31[2)>Q
MED9C^F*H'XU>*2<B&P ]/*/^-3P?'#Q!&?WVG6$P_P"!+_6M[3?CI92,JZGH
M\\'K) X<?D<5WNA>+="\2)G2]0CF<#+1'Y9%^JGFMFBBBHYIHK>%IIY4BC09
M9W8  >Y-<-K?QA\,Z6S16C2ZG*O&+<83/^\?Z9KC+_XY:U,2+#3+2V7L9&:1
MOZ"LE_C!XR<\7=JGLMLO]<TZ/XQ>,8SEKBTD'HUL/Z$5MZ=\=-0C8#4M'@F3
MNT$A1OR.17=^'_B;X9\0.D*79L[END-T-A)]CT/YUUM+15/5M2ATC2;K4;@$
MQ6T32,!U.!TKSD?'72B/^0->?]]K1_PO72O^@->?]]K1_P +UTK_ * UY_WV
MM=3X+\<V_C07;6UA/;):E0S2,#N)SP,?2NIHI&8(I9C@ 9)KS"3XYZ2DKH-(
MNV"L5#!UYP>M-_X7KI7_ $!KS_OM:/\ A>NE?] :\_[[6M_P?\2+3QCJDMC:
MZ;<0&*+S6DD8$ 9P!Q5#7OB_IFA:Y=:4^FW,[VK[&D1E )QSUK/_ .%ZZ5_T
M!KS_ +[6C_A>NE?] :\_[[6C_A>NE?\ 0&O/^^UH_P"%ZZ5_T!KS_OM:/^%Z
MZ5_T!KS_ +[6C_A>NE?] :\_[[6C_A>NE?\ 0&O/^^UH_P"%ZZ5_T!KS_OM:
M/^%ZZ5_T!KS_ +[6C_A>NE?] :\_[[6C_A>NE?\ 0&O/^^UH_P"%ZZ5_T!KS
M_OM:Z+P;\1+7QG?W%K:Z=/;_ &>,2.\C CDX X_&NPHI&8(I9C@ 9)KS"3XY
MZ2DKHND7;A6(#!UP<'K3?^%ZZ5_T!KS_ +[6C_A>NE?] :\_[[6M[PA\2;3Q
MAJTFGVNFW$!CB,K22," ,@=OK7:44445X'\:-0^U^-$M0<K9VRK]&8[C^F*\
M_HHKZ0^&&G_V=X TQ2,/.AG;_@1)'Z8KK**RO$^H#2O"^I7V<&&V<J?]K&!^
MI%?*XZ4M%=5\,M/_ +1\?Z:A&5@9IV_X"./UQ7:?';4/ETG3%/4O.X_\=7_V
M:O(:********V/".G?VKXNTJR(RLERA<?[(.3^@-?4E%><?%_P 7_P!D:.-$
MLY,7E^I\PJ>8XN_XGI^=>$TM%6-/N39:E:W8ZP3I(/P8'^E?62.)$5U.0P!!
MIU%>??&C4/LO@D6H.&O+E$Q_LCYC_(?G7@E%%>J_ K3]^HZKJ1'$4:0*?0D[
MC_(5[/17F7QQU#R?#=C8*>;JYW$>R#_$BO$*************EM+9KR\@M4!+
M3RK&,>YQ7UE;0+:VL5N@PL2!!] ,5+17GOQIU#[+X+2T5L->7*)CU4?,?Y"O
M!:**]7^!6G[K[5=28<1QI I^I)/\A7H/C3QI8>#M,$TX\Z[ER+>V4\N?4^BC
MUKY]\1>*-7\47AN-4NFD /R0KQ'&/0+_ %ZUDT4444^">:VG2>WE>&6,Y21&
M*LI]B*]L^&GQ+?6Y4T36W7[=C]Q<=//QV/\ M?SKTVBN7\9^/-,\'6N)C]HO
MI%S#:H>3[L>P]Z\&\2^,=:\57!DU*Z/D@Y2VC.V-/P[GW-8E%%%%)C-=]X&^
M*-_X=ECL=5DDO-+)QECND@'JI[CV_*O>;2[M[^TBN[699H)E#QR(<A@:FKAO
MB_J/V'P%<0AL->2I /<9R?T!KY\HHKWOX+Z=]D\%&[9<->W#R9]5'RC^1KT&
MBL3QEJ/]D^#]5O0<-';,$_WB-H_4BOET#  ]*6BO8?@=9+!INKZO(, NL2M[
M*-S?S%>4:I>MJ6K7E\QR;B=Y,^Q)(_2JM%%%%%%%%%%%>U_ S3O*T+4-28<W
M-P(U/L@_Q->HT5A^,]1_LGP=JMZ#ADMF"'_:;Y1^I%?+P& !2T5[#\"=.Q;:
MKJ;+R[I A^@W'^8KUNBBBBOESQCJ']J^,-5O <J]RP0_[*_*/T%8U%.AA:YG
MCMTSNE<(,>I.*^LK"U6RT^WM$ "P1+&,>PQ5BBN"^,FH?8_ KVZMAKR=(L>H
M!W'^5> 445ZE\"]/\S6-3U%AQ#"L2GW8Y_DOZUA_%W4/MWCVXB#92SB2$>QQ
MN/\ .N)HHHHHHHHKT#X+Z?\ :_&KW1&5LK9F^C-\H_3->^52UC5K70])N=3O
M'VPVZ%V]3Z >Y/%?+^NZS=>(-:N=5O&S+</G;GA%[*/8"J%%%(>AQUKZG\*7
M@U#PII5T#GS+6/)]PH!_45K45XM\=-0\S5-+TU3Q#$\S#W8X'Z"O+***]]^#
M.G_9/ XN67#7EP\F?51\H_D:[^BO"OC=J'VCQ7:6(.1:6V2/]ISG^0%><444
M4444444445U'PUT_^TO'^EQD96%S.W_  3_/%?2E%%>*_'34/,U?3-.5N(86
MF8>[' _137EM%%>\_"2"+1_AV^I7!\M)I);B1CV1>/Y+7CGB?Q!<^)]>N-4N
M6.)&Q$A/$<8^ZH_SUK)HH +,%4$L>  ,DU<&C:J8_,&EWNSU^SO_ (54961R
MCJ58=588(_"DHI\,\MM/'<0.8Y8F#HXZJP.0:^H_"^LKX@\-6&JC :XB!<#L
MXX8?F#6;X\\9V_@[13, LM]/E;:$GJ?[Q]A7SE?W]WJE]+?7T[3W$S;GD8\G
M_P"M[5!1129'K12T45Z?\'/%[V6I?\(W>29MKHEK4L?N2=2OT/\ /ZU[;7CW
MQVU',VDZ8IZ!YW'_ (Z/ZUY)12'H:^IO">G?V3X4TRQQ@Q6R!A_M$9/ZDUKT
M5YU\:]1^R^#X;)6PU[<J"/55^8_KBO"***]LT4_\(W\"9KO[LEQ;R2 ]\R':
MOZ$?E7B0X%+11111111112=*^E_AUIW]E^ ]*@*[7>'SG^KG=_45TU%><_&S
M4?LWA&"R5L->7*@^ZJ,G^E>$T45]%?"G3_L'@"Q)&'N2T[?\"/'Z 5V5%%%4
M-=OETS0;^^9MHM[=WS[@'%?*19G)=OO,<GZFBBNC^'NG_P!I^/-)@*Y5)O.;
MZ("W]*^F:**\:^.VH;KS2=-#<(CSL/J=H_DU>4445[S\%K 6G@N2\88-W<N^
M3_=7"C^1KQ77[\ZIXAU&_)S]HN7<'VSQ^F*H458TZRDU+4[6PB.'N9EB4XSC
M)QFO4?\ A0\W_0P)_P" W_V5'_"AYO\ H8$_\!O_ +*C_A0\W_0P)_X#?_94
M?\*'F_Z&!/\ P&_^RH_X4/-_T,"?^ W_ -E1_P *'F_Z&!/_  &_^RKLO /@
M(>"EO2]Z+R2Z*X81[-H&>.I]:[&O#OC%XO\ [2U-?#]G)FULFW7!4\/+Z?\
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MYX,M?#L5Y]C2$1!G";LA!TQGUKBO^%#G_H8#_P" _P#]>C_A0Y_Z& _^ _\
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M] :^>:**UO#/B2[\*ZK_ &E8Q0R3^68QYRD@ XR>#UXKK?\ A=OB?_GVT_\
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M +5\2Z;88R)[E%;_ '<Y/Z9KW'XP6SW'P^N&0<0312-[ -C^M?/E%%=UX/\
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M_P Q7KM%%%%1SRK!!),YPL:EB?8#-?)U_=M?ZC<WCDEKB9Y#GW)-045H^';
MZKXDTVPQD3W**P]LY/Z U]5 8&!2TUW5$9V.%49)/85\HZQ?-J6M7U\W6XN'
MD_-C5.BBBBBBBBBO8/@3I^(-6U-EY9T@0_0;C_,5ZY7*>-O 6G^,K4,[?9K^
M)<0W*C/_  %AW'\J\*\1>#-=\+S,NHV3^2#\MS$-T;?CV_&L+K2T445);W$]
MG<QW-M*\,\3!DD0X*D=Q7T9\//& \7: )9MJWUL1'<J.A/9A['_&O&_BE,9O
MB)JF3Q&8T'X(O_UZY.BM'PY:B^\3:7:L,B:[C4C_ ($*^JZ***\9^.NHA]0T
MK35;_51O.X_WC@?R->4T4AX&:]0\6NVD?!GP]I1XDO&61AZ@9?\ F5KS"BDK
MZ-^%>G?V=X L,KA[G=.P_P!X\?H!7845QWQ5U+^S? %\ </=;;=?^!'G_P =
M!KYTHHKW#X':=Y'AJ]U!A@W5SM'T0?XD_E7IE%%?/WQCU'[;XY:W#92RMTC'
MU/S'^=<)15K2[)M2U:SL4!S<3I'Q[D"OJ^*-8HDC085%"@#L!3ZX?XOZC]A\
M!7$0;#7DJ0#W&<G]%-?/=%%%%%%%%%>Y?!#3OL_A:[OR,-=W) /JJ# _4M7I
M5%%%(2 "2< =37RIX@OSJGB+4;\G/VBY=Q],G'Z5GT5/8V<FH:A;V4/^LN)5
MC3/J3BO2?^%$ZM_T&[/_ +\O_C1_PHG5O^@W9_\ ?E_\:/\ A1.K?]!NS_[\
MO_C7.>,OA[=>"[.VN+K4H+DW,AC5(XV4C R3S7)445ZY\"=/S)JVIL.@2!3^
M;'_V6N/^*.H?VA\0-1(.5MRL"_\  1S^I-<G12'@5ZC:? ^_N;.&=M:AB:6-
M7*& G:2,XZU-_P *(O?^@]!_X#G_ !H_X41>_P#0>@_\!S_C1_PHB]_Z#T'_
M (#G_&C_ (41>_\ 0>@_\!S_ (UK^%?A!-X?\26FK7&JQ7*6S%A$L)4DX('.
M>Q.:[SQ%KEKX<T.YU6[/R0+E5SR[=E'U-?,&J:E=:SJ=QJ5X^^>Y<NY[#T ]
M@.*JT5ZG\&O"'VN\;Q+>Q_N;<E+0,/O/W?\ #H/?/I7M->$_&W3_ +-XMMKU
M1\MW:C)]64X_D17G-%:GA>\^P>*]*N\X\N[CR?8M@_H:^J*\,^-^H>?XGLK!
M6^6UMMS#T9C_ ( 5YM117T/\)-/^P> +1R,-=N\Y_$X'Z 5VM%%%%<Y\0=1_
MLSP+JUP&PS0&)?J_R_UKYE'2EHKN/A!I_P!M\>0S%<I9PO*?8_='\Z^A**PO
M&VH_V5X+U6[!PRVS*OU8;1_.OE\#  I:*VO"?A>Y\7:S_9EK.D#")I&DD4D*
M!CL/<BNV_P"%$ZM_T&[/_OR_^-'_  HG5O\ H-V?_?E_\:/^%$ZM_P!!NS_[
M\O\ XUQ/BSPS+X2UG^RY[N*ZD$2R,T:E0N<\<_3]:Q:**^B/A-I_V'P!9.1A
MKIGG/ODX'Z 5VE%-=$D0HZAE88*L,@UR>L_##PIK)9WTX6DS<F2U/EG/TZ?I
M7"ZO\#;Z+<^CZK%<#M%<KL;_ +Z&1^E<'K?A+7O#ISJFF30QYQYH&Z,_\"'%
M8]%%=Y\&]3>R\<+:;L1WT#HP[94;@?T(_&LOXEH4^(>K@]Y%/YHIKEZ*V_!3
MK'XWT1GX47L?/XU]0T44A(4$DX Y)-?,7C?7/^$A\7W^H(V82_EP_P"XO /X
MXS^-8-%6M*T^35M7M-.B!+W4RQC'N>3^6:[WXTW*+KNFZ3#Q%8V8POH2<#]%
M%><44J(TLBQK]YV"CZGBOK+3K5+'3+6TC&$@A2-1[  59HKQSXZ:L&N-,T=&
M^X&N) #Z_*N?UKR:BD)P,FOIGX?::=*\"Z5;LNUVA$KC_:?YC_.NDHI"0 2>
M@KY6\2:@=5\3:E?YR)[EV4^V<#] *S:*['X4Z=_:'C^R8KE+57G/L0,#]37T
M717CWQVU',VDZ8IZ!YW'Y*/ZUY)12$X!/I7IME\$-4N[&"Y.LVT1FC5S&8&)
M7(SC.:F_X41J?_0>M/\ P';_ !H_X41J?_0>M/\ P';_ !KE/&G@>;P4]I'<
M:C#=R708A8XRNT#')R?>N8HI"< GTKZ<\!:=_97@C2K4KA_LXD?ZM\Q_G70T
M445C^+=0&E>$M4O<\Q6S[?J1@?J:^6AG')R>YI:*ZWX6Z?\ VA\0-/!&5M]T
M[>VT<?J17T?117B/QRU#SO$&GZ>K<6]N9&'NQ_P7]:\QHHKZ ^$MHNF?#R.[
ME 7[0\EPQ_V>@/Y+7@^HW;:AJ=U>O]ZXF>0_BQ-5Z*T/#]@=4\1:=8 9^T7*
M(1[9Y_3-?58 4 #@#@4M%%%%>"?%OQ?_ &YK@TBTDS8Z>Q#%3Q)+W/T'0?C7
MGU%%:%OX@UJSMTM[;5KR"%!A8XYBJK] *D_X2GQ#_P!!S4/_  (;_&JM[JFH
M:GL^WWUQ=>7G9YTA;;GKC-5:*%<QL'4X*D$'TQ7UGIMR+W3+6Z7I/"D@_%0?
MZU\W?$'4/[3\=ZM.&W*D_DK]$&W^8-<[10%9V"(,LQP!ZDU]7:)8KIFAV-BH
MP+>W2/\ )0*O44445YI\<-0\CPQ9V /-U<@D>R@G^9%>'445[!\"=/Q#JVIL
M.69($/T&X_S6O7**\Z^-FH?9O!\-F#AKRY4$?[*Y8_J!7A%%%>L_ G3]UQJV
MI$?=5(%/U^8_TKV.BBOF3Q]J']I^.M6N VY1.8E/L@VC^5<]10$:1@B_><A1
M]3Q7J_Q \0:_X+FT;2M(OFM($TY R*BD%P2">17(_P#"SO&7_0;D_P"_2?X4
M?\+.\9?]!N3_ +])_A3X?B?XO2>-I-9D:,."R^6G(SSVKZ,@GCN;>.>)@T<J
M!T8=P1D&I*9+%'/$T4T:R1N,,CC((]Q7S7\0]&M-!\:WMC8J%M_ED1!T3<,[
M?PKFJ*ZKX8HTGQ#TH)U#NQ^@4YK2^,MB;7QT;C;A;NW1P?4CY3_(5P=%/MYY
M+6YBN(CB2%PZGW!R*^I_#VMVWB'0[75+5P4G0%@/X&_B4^X-:5%>>?%?QK'H
MFD/HUE*#J-ZFUMIYAC/4GT)Z#\Z\%I:*]*^"WAXWVO3:W,G[FQ79$2.LC#^@
M_F*P_BI*TOQ#U'=_ (T'T"BN1HI\$I@N(I@,F-U?'K@YKZOTV_@U/3;>^MI!
M)#<1AT8>A%6JBNKJ"RM9;JYE6*&)2SNQP% [U\P^+]>/B7Q1>ZIR(I'VP@]1
M&O"_X_C6-15[0],DUG7;'38QEKF=4/L,\G\LU]5Q1I#$D48PB*%4>@%/HK(\
M6:C_ &3X4U.^S@PVSE3_ +1&!^I%?+(Z4M%>M_ G3LS:MJC#H$MT/_CS?^RU
M[#17SI\5]0^W^/[Q0<I:HD ^H&3^IKCJ*OZ#IYU7Q#I^GJ,_:+E$/TSS^E?5
MBJ$4*HP , 4M%?/_ ,9-1^V>.6M@V5LK=(\>Y^8_S'Y5P=%6M*LFU+5[.Q3[
MUQ.D8_%@*^KXXUAB2)!A$4*H] *?1117G_QGU#[)X(^S!L->7"1X_P!D?,?Y
M#\Z\#HHKU3X%:?YFIZIJ3+Q%$D*GT+')_D*]HHHKYI^(^H?VEX]U64'*Q2B%
M?H@ KF:*3!;@=3P*^BM>(\+_  EFA7Y'AT]8 /\ :8!3^I-?.H&!BEHJ_H>L
M7&@:Q!JEI'%)/;DE!,I*Y(QG (]:[/\ X79XI_Y]]-_[\O\ _%4?\+L\4_\
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M*U;FVAO+66VN(Q)#,A1T;HP(P17S7XW\'W7@_6VMF5GLI26M9^S+_=/^T/\
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M_P"Q-)_Z!=G_ . Z?X4?V)I/_0+L_P#P'3_"C^Q-)_Z!=G_X#I_A1_8FD_\
M0+L__ =/\*/[$TG_ *!=G_X#I_A1_8FD_P#0+L__  '3_"C^Q-)_Z!=G_P"
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MZ98:CL^VV4%SY>=GFQAMN>N,U5_X1G0?^@-8_P#@.O\ A1_PC.@_] :Q_P#
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7-IVA62V6F6D=K O.U!U/J3U)^M7J_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
